Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation (Q39044824)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 January 2015

Language	Label	Description	Also known as
English	Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation	scientific article published on 24 January 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

carbamoyl phosphate synthetase I deficiency disease

1 reference

based on heuristic

inferred from title

Kurt Leibundgut

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jean-Marc Nuoffer

7

0 references

author name string

Alexander Laemmle

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Dagmar Hahn

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Liyan Hu

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Véronique Rüfenacht

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Matthias Gautschi

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Johannes Häberle

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

24 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

114

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

438-444

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Hyperammonemia after high-dose chemotherapy and stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Idiopathic hyperammonaemia syndrome following allogeneic peripheral blood progenitor cell transplantation (allo-PBPCT)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Acute encephalopathy and hyperammonaemia complicating treatment of acute lymphoblastic leukaemia with asparaginase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Hyperammonemia encephalopathy: an important cause of neurological deterioration following chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Development of hyperammonemic encephalopathy in patients with multiple myeloma may be associated with the appearance of peripheral blood myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Hyperammonemic encephalopathy in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Idiopathic hyperammonemia following an unrelated cord blood transplant for mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Hepatic Glutamine Synthetase Deficiency in Fatal Hyperammonemia after Lung Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Fatal hyperammonemia after orthotopic lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Risk of transient hyperammonemic encephalopathy in cancer patients who received continuous infusion of 5-fluorouracil with the complication of dehydration and infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

High incidence of symptomatic hyperammonemia in children with acute lymphoblastic leukemia receiving pegylated asparaginase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Identification of novel mutations of the human N-acetylglutamate synthase gene and their functional investigation by expression studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Phytohemagglutinin stimulation of lymphocytes improves mutation analysis of carbamoylphosphate synthetase 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Analysis of mRNA transcripts improves the success rate of molecular genetic testing in OTC deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1α protein under hypoxic conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Activity and interactions of levofloxacin, linezolid, ethambutol and amikacin in three-drug combinations against Mycobacterium tuberculosis isolates in a human macrophage model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Enhancement of Carboplatin- and Quercetin-Induced Cell Death by Roscovitine Is Akt Dependent and p53 Independent in Hepatoma Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Development and validation of a PCR-based assay for the selection of patients more likely to benefit from therapeutic treatment with alkylating drugs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Molecular and biochemical characterisation of a novel mutation in POLG associated with Alpers syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Inhibition of both etoposide-induced DNA fragmentation and activation of poly(ADP-ribose) synthesis by zinc ion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Mitochondrial toxicity associated with linezolid

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Linezolid-induced lactic acidosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Deletions in the mitochondrial DNA and decrease in the oxidative phosphorylation activity of children with Fanconi syndrome secondary to antiblastic therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Mitochondrial carbonic anhydrase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Liver carbonic anhydrase and urea synthesis. The effect of diuretics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Urea cycle regulation by mitochondrial sirtuin, SIRT5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Overexpression of SIRT5 confirms its involvement in deacetylation and activation of carbamoyl phosphate synthetase 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Lysine glutarylation is a protein posttranslational modification regulated by SIRT5

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Mitochondrial encephalocardio-myopathy with early neonatal onset due to TMEM70 mutation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Regulation of mitochondrial carbamoyl-phosphate synthetase 1 activity by active site fatty acylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Genetic variation in the urea cycle: a model resource for investigating key candidate genes for common diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Carbamoyl phosphate synthetase polymorphisms as a risk factor for necrotizing enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.01.002

7 January 2021

Identifiers

10.1016/J.YMGME.2015.01.002

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39044824&oldid=1805088344"